Pengaruh Pemberian Metilprednisolon Oral Terhadap Perubahan Kadar C-Reactive Protein Penderita Kanker Kepala Leher yang Diberikan Radioterapi
DOI:
https://doi.org/10.36408/mhjcm.v3i2.217Abstract
Latar belakang : Radioterapi dapat memberikan efek inflamasi terus menerus pada kanker kepala leher (KKL). C-reactive protein (CRP) merupakan protein fase akut sebagai parameter status inflamasi terkini. Metilprednisolon bekerja pada efektor akhir untuk menginhibisi inflamasi. Penelitian ini bertujuan untuk mengetahui pengaruh pengaruh pemberian metilprednisolon terhadap kadar CRP pada penderita KKL yang mendapat radioterapi. Metode : Penelitian intervensi yang membandingkan perubahan kadar CRP pasien KKL dengan radioterapi antara kelompok yang diberikan metilprednisolon (n=15) dan yang tidak diberikan metilprednisolon (n=15) pada sebelum, 7 kali radioterapi dan 14 kali radioterapi. Hasil : Hasil penelitian didapatkan peningkatan bermakna kadar CRP pada kelompok metilprednisolon dan kontrol setelah 7 kali radioterapi (p<0,05). Perbedaan bermakna perubahan kadar CRP antara kelompok metilprednisolon dan kontrol setelah 14 kali radioterapi (p<0,05). Simpulan : Pemberian metilprednisolon dapat mempengaruhi perubahan kadar CRP pasien KKL yang diberikan radioterapi
Downloads
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.